Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pitofenone is a small molecule antispasmodic (spasmolytic) drug used to relieve pain and spasms of smooth muscles in the stomach, intestines, urinary tract, biliary tract, and uterus. It is commonly indicated for conditions such as menstrual cramps, gastrointestinal colic, kidney stones, gallstones, and painful menstruation. Pitofenone works by suppressing muscle spasms through anticholinergic (antimuscarinic) activity—blocking acetylcholine at muscarinic receptors—and by inhibiting acetylcholinesterase. This results in relaxation of vascular and extravascular smooth muscles similar to papaverine. It is often used in combination with fenpiverinium bromide and metamizole sodium for enhanced analgesic and anti-inflammatory effects[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pitofenone.